Accutrend is clear favourite in hospital glucose trials
This article was originally published in Clinica
Executive Summary
Boehringer Mannheim's Accutrend near-patient glucose meter came out as a clear favourite in several trials presented at ICCC, although a UK group had problems with quality during the first few months of use.